Printer Friendly

COPLEY PHARMACEUTICAL ANNOUNCES PUBLIC OFFERING OF COMMON STOCK

 CANTON, Mass., April 27 /PRNewswire/ -- Copley Pharmaceutical, Inc. (NASDAQ: CPLY) announced today the public offering of 1.2 million primary shares of common stock at a price of $36 per share. Of the 1.2 million shares offered to the public, 500,000 shares will be offered by the company and 700,000 will be offered by certain stockholders of the company. Bear, Stearns & Co. Inc. and Tucker Anthony Incorporated are managing underwriters for the offering.
 Copley Pharmaceutical, Inc. develops, manufactures and markets a broad range of off-patent prescription and over-the-counter pharmaceutical products in a variety of dosage forms and strengths, including extended-release products. The company markets its products to distributors, retail chains, wholesalers, hospitals, government agencies and managed care entities.
 The net proceeds to the company of the offering will be used for building construction, capital equipment, research and development, collaborative arrangements, potential acquisitions, working capital and general corporate purposes. The company will not receive any proceeds from shares sold by the selling stockholders in the offering.
 A prospectus may be obtained by contacting the Investor Relations Department of the company at 617-821-6111.
 -0- 4/27/93
 /CONTACT: Steven N. Tannenbaum, executive vice president-finance of Copley Pharmaceutical, 800-325-6111 or 617-821-6111/
 (CPLY)


CO: Copley Pharmaceutical, Inc. ST: Massachusetts IN: MTC SU: OFR

DJ -- NE021 -- 1493 04/27/93 14:56 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 27, 1993
Words:221
Previous Article:OUTLET COMMUNICATIONS ANNOUNCES FIRST QUARTER OPERATING RESULTS; REGISTERS THIRD CONSECUTIVE QUARTERLY PROFIT
Next Article:RECOGNITION ANNOUNCES THE TRACE 2000 HIGH PERFORMANCE DOCUMENT IMAGE SYSTEM AND TRACE 1000E DOCUMENT IMAGE SYSTEM UPGRADE OPTION
Topics:


Related Articles
VERTEX PHARMACEUTICALS INTENDS TO FILE REGISTRATION STATEMENT WITH SEC TO SELL 2 MILLION SHARES OF COMMON STOCK
UNDERWRITERS' OPTION EXERCISED IN ARAMED UNIT OFFERING AND GENSIA COMMON STOCK OFFERING
ISIS PHARMACEUTICALS ANNOUNCES PUBLIC OFFERING OF ONE MILLION SHARES OF COMMON STOCK
ISIS PHARMACEUTICALS ANNOUNCES PUBLIC OFFERING OF ONE MILLION SHARES OF COMMON STOCK
VERTEX PHARMACEUTICALS ANNOUNCES PUBLIC OFFERING OF 2 MILLION SHARES OF COMMON STOCK AT $13.75 PER SHARE
VERTEX PHARMACEUTICALS ANNOUNCES PUBLIC OFFERING OF TWO MILLION SHARES OF COMMON STOCK AT $13.75 PER SHARE
SCICLONE PHARMACEUTICALS INC. INITIAL PUBLIC OFFERING
WATSON PHARMACEUTICALS ANNOUNCES FILING OF REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING
COPLEY PHARMACEUTICAL FILES REGISTRATION STATEMENT FOR SECOND PUBLIC OFFERING
ROBERTS PHARMACEUTICAL CORPORATION FILES PROPOSED OFFERING OF COMMON STOCK WITH SEC

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters